2016-06-27 16:51:54 UTC

Freston 2016 Preview: Inflammation and the Development of Metaplasia

June 27, 2016

Learn about session five of the 2016 Freston Conference taking place in Chicago, IL, this August.

This week we continue our preview of the 2016 James W. Freston Conference with insight on session five, Inflammation and the Development of Metaplasia. In case you missed them, make sure to check out previews for the other sessions on origins of metaplasia, stem cells and the GI tract and where metaplasia of the stomach and esophagus originate.

The 2016 conference will take place Aug. 19 to 21 in Chicago, IL. 

Inflammation and the Development of Metaplasia
Session five will elaborate on the key role of inflammation in the development of metaplasia in the stomach and esophagus. Prominent researchers Richard M. Peek, Jr., MD, AGAFRhonda F. Souza, MD, AGAF; and Juanita L. Merchant, MD, PhD will lead attendees in:

  • Understanding how host and microbial genetic interactions augment the risk of developing premalignant lesions.
  • Determining if esophageal microbial interactions with Barrett's metaplasia augments its progression to neoplasia.
  • Examining the hedgehog ligand and its role in parietal cell atrophy transitioning to metaplasia.

Stay tuned to the AGA website for details on session six. To learn more about the conference and to register, visit the conference web page.

Funded by the Takeda Endowment in support of the James W. Freston Single Topic Conference.

A word from Co-Director Stuart Spechler, MD, AGAF

More on Barrett's Esophagus

Course for APPs benefits all experience levels

April 16, 2018

AGA's popular course for advanced practice providers will take place Aug. 10 through 12 in Chicago, Illinois.

APPs: Enhance your delivery of patient care

March 28, 2018

AGA's popular course for advanced practice providers will be held this summer in Chicago.

How to Talk with Your Patients About PPIs and Cognitive Decline

Feb. 22, 2018

More information clearing concerns about the use of proton pump inhibitors (PPIs).